Location: Dallas, TX
CIK: 0002106181 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $120M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 3,722,840 | $15.38M | 12.8% | $4.13 * | $3.63 | +0.1% | COM NEW | 98420X202 |
| BOXX | Alpha Architect 1-3 Month Box ETF | 118,422 | $13.77M | 11.5% | $116.29 | $115.10 | — | ALPHA ARCH 1-3 | 02072L565 |
| SRZN | Surrozen Inc | 385,178 | $11.22M | 9.3% | $29.13 * | $16.18 | +37.4% | COM NEW | 86889P208 |
| RLAY | Relay Therapeutics Inc | 901,457 | $8.969M | 7.5% | $9.95 * | $7.14 | +16.3% | COM | 75943R102 |
| SION | Sionna Therapeutics Inc | 197,072 | $7.901M | 6.6% | $40.09 * | $37.92 | +3.5% | COM | 829401108 |
| MANE | Veradermics Inc | 102,879 | $6.497M | 5.4% | $63.15 | $63.15 | — | COMMON STOCK | 922967104 |
| ORKA | Oruka Therapeutics Inc | 118,524 | $5.814M | 4.8% | $49.05 * | $27.86 | +16.5% | COM | 687604108 |
| PHVS | Pharvaris NV | 198,772 | $5.615M | 4.7% | $28.25 * | $24.09 | +11.0% | COM | N69605108 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,337,556 | $5.016M | 4.2% | $3.75 * | $3.33 | 0.0% | COM | 00461U105 |
| SEPN | Septerna Inc | 194,544 | $4.675M | 3.9% | $24.03 * | $23.88 | +11.0% | COM | 81734D104 |
| CMPS | Compass Pathways PLC | 819,692 | $4.533M | 3.8% | $5.53 | $6.90 | — | SPONSORED ADS | 20451W101 |
| IKT | Inhibikase Therapeutics Inc | 2,672,608 | $4.49M | 3.7% | $1.68 * | $1.64 | +5.7% | COM NEW | 45719W205 |
| LONA | LeonaBio Inc | 393,701 | $4.047M | 3.4% | $10.28 * | $4.58 | +22.8% | COM | 04746L203 |
| GLTO | Damora Therapeutics Inc | 139,000 | $3.6M | 3.0% | $25.90 | $25.80 | 0.0% | COM NEW | 36322Q206 |
| QURE | Uniqure NV | 211,702 | $3.461M | 2.9% | $16.35 * | $23.55 | 0.0% | SHS | N90064101 |
| MLTX | MoonLake Immunotherapeutics | 175,734 | $3.276M | 2.7% | $18.64 * | $11.80 | +36.0% | CLASS A ORD | 61559X104 |
| TYRA | Tyra Biosciences Inc | 74,465 | $2.852M | 2.4% | $38.30 * | $18.37 | +64.7% | COM | 90240B106 |
| GOSS | Gossamer Bio Inc | 7,471,840 | $2.454M | 2.0% | $0.33 * | $2.26 | 0.0% | COM | 38341P102 |
| TNYA | Tenaya Therapeutics Inc | 2,000,000 | $1.385M | 1.2% | $0.69 | $1.36 | -46.6% | COM | 87990A106 |
| PEPG | PepGen Inc | 729,961 | $1.292M | 1.1% | $1.77 * | $5.83 | 0.0% | COM | 713317105 |
| KRRO | KORRO BIO INC | 109,376 | $1.238M | 1.0% | $11.32 * | $10.79 | 0.0% | COM | 500946108 |
| TIL | Instil Bio Inc | 139,849 | $1.152M | 1.0% | $8.24 * | $7.86 | 0.0% | COM NEW | 45783C200 |
| KLRS | Kalaris Therapeutics Inc | 135,585 | $782K | 0.7% | $5.77 * | $6.39 | +46.6% | COM | 482929106 |
| DMAC | DiaMedica Therapeutics Inc | 62,488 | $423K | 0.4% | $6.77 * | $7.48 | +11.1% | COM NEW | 25253X207 |
| LOOP | LONGEVERON INC | 347,539 | $361K | 0.3% | $1.04 * | $1.20 | 0.0% | COM | 543518104 |